Back from the grave
It’s been a spooky, spirited season for prescription digital therapeutics (PDTs). Around Halloween, RESET and RESET-O—two PDTs that were laid to rest after their initial developer, Pear Therapeutics, filed for bankruptcy—came back to life as part of PursueCare’s virtual treatment offering for substance use disorders sold to health plans. Not long before, Big Health earned FDA clearance for PDTs addressing anxiety and insomnia, while Highmark rebooted PDT coverage in its commercial plans, spurring optimism among developers. With CMS’s 2025 billing codes for behavioral health PDTs now finalized, the cauldron of possibility is brewing—but only time will tell if these programs are back for good, or if they’re dead assets walking.
+ Are you a talented, experienced writer with deep expertise in healthcare and technology? Rock Health Advisory is hiring a content writer to support our thought leadership efforts. Learn more and apply here!
Headlines
Oracle Announces New AI-Powered EHR
EHR built from scratch—not from Cerner—touts voice control and AI capabilities CNBC
Nvidia Plans To Provide The Building Blocks Of AI In Health Tech
Supporting health-related AI use cases, on the heels of a partnership to advance AI adoption Endpoints News
Digital Hypertension Solutions: Medication Management Shows Superior Results
PHTI compares “usual care” to three categories of digital hypertension solutions HIT Consultant
Why Your Next Prescription Could Include An App
FDA draft guidance on prescription drug-use related software (PDURS) has players suiting up Axios
State Of Health Tech 2024
The name of the game this year is resilience Bessemer Venture Partners
Bariatric Surgeries Plunge In GLP-1 Era
Studys shows 25.6% decline in surgery for weight care, 132.6% increase in GLP-1 prescriptions Becker’s Hospital Review
Recent Funding
- CredibleMind picks up $7.5M to expand solutions for mental health and wellbeing
- Hello Patient launches with $6.3M to develop AI agents to automate patient phone calls
- Dental staffing marketplace Toothio grabs $5M
- Ataraxis AI secures $4M to apply multi-modal algorithms to cancer treatment selection